Immucell (ICCC) Change in Receivables (2010 - 2025)

Immucell (ICCC) has reported Change in Receivables for 16 consecutive years, with $864243.0 the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Change in Receivables fell 40.94% year-over-year to $864243.0; the trailing twelve-month figure through Dec 2025 stood at -$352124.0 (down 122.21% YoY), and the FY2025 full-year result was -$352124.0, down 122.21% from the prior year.
• Change in Receivables advanced to $864243.0 in Q4 2025 per ICCC's latest filing, from $175943.0 in the prior quarter.
• Across five years, Change in Receivables topped out at $1.5 million in Q4 2024 and bottomed at -$1.2 million in Q2 2022.
• Historically, Change in Receivables has averaged $81110.4 across 5 years, with a median of $280050.0 in 2021.
• The sharpest annual moves came in 2022 and 2023: Change in Receivables sank 264.1% in 2022, then jumped 896.63% in 2023.
• Over 5 years, Change in Receivables stood at $271974.0 in 2021, then sank by 79.13% to $56770.0 in 2022, then soared by 465.08% to $320798.0 in 2023, then soared by 356.12% to $1.5 million in 2024, then slumped by 40.94% to $864243.0 in 2025.
• According to Business Quant data, Change in Receivables over the past three periods registered $864243.0, $175943.0, and -$967602.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.